EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Bayesian Integrated Learning of Longitudinal Dose‐Response Relationships via Decentralized Clinical Trials

Jingyi Zhang iD, Tuo Wang, Yongming Qu, Fangrong Yan iD, Suyu Liu iD, Ruitao Lin iD

Statistics in Medicine · 2025-12 · 44 (28-30)

DOI: 10.1002/sim.70338 ↗

At a glance

Journal article in Statistics in Medicine, published online on 2025-12-03. Written by Jingyi Zhang and 5 co-authors. Institution: Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China. Major MEDLINE topics: Dose-Response Relationship, Drug, Clinical Trials, Phase II as Topic. Cited 1 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Decentralized clinical trials (DCTs) extend trial activities beyond traditional sites, enhancing access, convenience, efficiency, and result generalizability. They are particularly promising for chronic conditions like diabetes and obesity, which require longer study durations to evaluate drug effects. However, decentralized data collection raises concerns about increased variability and potential biases. This paper presents a novel Bayesian integrated learning procedure to analyze dose‐response relationships using longitudinal data from a phase II DCT that combines centralized and decentralized data collection. We generalize a parametric exponential decay model to handle mixed data sources and apply Bayesian spike‐and‐slab priors to address biases and uncertainties from decentralized measurements. Our model enables data‐adaptive integration of information from both centralized and decentralized sources. Through simulations and sensitivity analyses, we show that the proposed approach achieves favorable performance across various scenarios. Notably, the method matches the efficiency of traditional trials when decentralized data collection introduces no additional variability or error. Even when such issues arise, it remains less biased and more efficient than naïve methods that rely solely on centralized data or simply pool data from both sources.

Subjects

MeSH terms (MEDLINE)

Dose-Response Relationship, DrugClinical Trials, Phase II as TopicBayes TheoremHumansLongitudinal StudiesComputer SimulationModels, StatisticalBias

Author keywords

data integrationdecentralized clinical trialdose‐response modelphase II trialspike‐and‐slab prior

Authors and institutions

  • Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
  • Department of Global Statistical Sciences, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID profiles: Jingyi Zhang, Fangrong Yan, Suyu Liu, Ruitao Lin

Cite

APA

Zhang, J., Wang, T., Qu, Y., Yan, F., Liu, S., & Lin, R. (2025). Bayesian Integrated Learning of Longitudinal Dose‐Response Relationships via Decentralized Clinical Trials. Statistics in Medicine, 44(28-30). https://doi.org/10.1002/sim.70338

Vancouver

Zhang J, Wang T, Qu Y, Yan F, Liu S, Lin R. Bayesian Integrated Learning of Longitudinal Dose‐Response Relationships via Decentralized Clinical Trials. Statistics in Medicine. 2025;44(28-30). doi:10.1002/sim.70338

BibTeX
@article{Zhang2025,
  author = {Zhang, Jingyi and Wang, Tuo and Qu, Yongming and Yan, Fangrong and Liu, Suyu and Lin, Ruitao},
  title = {Bayesian Integrated Learning of Longitudinal Dose‐Response Relationships via Decentralized Clinical Trials},
  journal = {Statistics in Medicine},
  year = {2025},
  volume = {44},
  number = {28-30},
  doi = {10.1002/sim.70338}
}
Start for free →